Inhibitors Directed towards Caspase-1 and -3 Are Less Effective than Pan Caspase Inhibition in Preventing Renal Proximal Tubular Cell Apoptosis
Authors:
- A. Meguid El NahasANA. Meguid El Nahas
- Marie FisherMFMarie Fisher
- Bart WagnerBWBart Wagner
- Linhong HuangLHLinhong Huang
- Ian StorieISIan Storie
- David BarnettDBDavid Barnett
- Jonathan BarrattJBJonathan Barratt
- Alice C. SmithASAlice C. Smith
- Timothy S. JohnsonTJTimothy S. Johnson
- 1 February 2004
- journal article
- Published by S. Karger AG in Nephron Experimental Nephrology
- Vol. 96 (2) , e39-e51
Abstract
Background: Uncontrolled apoptosis contributes to tubular cell deletion in renal scarring. Caspase-3 has a central role in the execution of apoptosis and may provide a target for regulating cell death. Here we evaluate three caspase inhibitors: B-D-FMK (pan caspase inhibitor), Z-DEVDFMK (predominantly Caspase-3 inhibitor) and Z-VAD-FMK (predominantly Caspase-1 and -3 inhibitor) to ameliorate apoptosis induced by cisplatin in rat proximal tubular (RPT) cells. Methods: Caspase-3 activity (substrate cleavage assay) and protein (immunocytochemistry and Western blotting), apoptosis (Annexin V flow cytometry, in situend labelling of fragmented DNA, light/electron microscopy and DNA laddering) and cell survival (trypan blue exclusion and propidium iodide flow cytometry) were determined in RPT cells exposed to cisplatin with and without caspase inhibitors. Results: Cisplatin induced a dose-dependent increase in Caspase-3 activity and 8-fold of increase in apoptosis (p < 0.01) when applied for 24 h at 100 µM. B-D-FMK (40 µM), Z-DEVD-FMK (15 µM) and Z-VAD-FMK (22 µM) almost completely inhibited the 25-fold increase in Caspase-3 activity and decreased apoptosis from 15.9 ± 4.4 to 2.0 ± 0.6% (p < 0.01), 15.0 ± 2.2 and 15.0 ± 2.2% respectively. DNA ladders were visible in cisplatin-treated cells, which disappeared following addition of B-D-FMK and decreased with Z-VAD-FMK and Z-DEVD-FMK. Cisplatin reduced cell survival to 61% by trypan blue exclusion. B-D-FMK and Z-VAD-FMK increased this to 87 and 75%, but Z-DEVD-FMK had no significant effect. Conclusions: Cisplatin causes an increase in RPT apoptosis that is associated with increased Caspase-3 activity. All caspase inhibitors were equally effective at reducing Caspase-3 activity, however the pan caspase inhibitor B-D-FMK was more effective at preventing apoptosis and increasing cell survival. Therefore, pan caspase inhibition offers the greatest potential for the prevention of renal tubular cell deletion by uncontrolled apoptosis.Keywords
This publication has 13 references indexed in Scilit:
- Effects of caspase inhibition on the progression of experimental glomerulonephritisKidney International, 2003
- Caspase 3 inhibition attenuates hydrogen peroxide‐induced DNA fragmentation but not cell death in neuronal PC12 cellsJournal of Neurochemistry, 2001
- Calpain Inhibition Protects against Virus-Induced Apoptotic Myocardial InjuryJournal of Virology, 2001
- Cleavage of the Actin-capping Protein α-Adducin at Asp-Asp-Ser-Asp633-Ala by Caspase-3 Is Preceded by Its Phosphorylation on Serine 726 in Cisplatin-induced Apoptosis of Renal Epithelial CellsJournal of Biological Chemistry, 2000
- Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-βNature, 2000
- The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cellsOncogene, 1999
- Angiotensin II, nitric oxide, and end-organ damage in hypertensionKidney International, 1998
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Longevity in Caenorhabditis elegans reduced by mating but not gamete productionNature, 1996
- Unraveling chemosensory diversityCell, 1995